Thalidomide	NNP
reduces	VBZ
IL-18	NN
,	,
IL-8	NN
and	CC
TNF-alpha	NN
release	NN
from	IN
alveolar	JJ
macrophages	NNS
in	IN
interstitial	JJ
lung	NN
disease	NN
.	.

Thalidomide	NN
exhibits	VBZ
diverse	JJ
actions	NNS
of	IN
anti-inflammation	JJ
,	,
immunomodulation	NN
and	CC
anti-angiogenesis	NN
.	.

The	DT
efficacy	NN
of	IN
thalidomide	NN
treatment	NN
in	IN
sarcoidosis	NN
with	IN
lupus	NN
pernio	NN
is	VBZ
thought	VBN
to	TO
be	VB
due	JJ
to	TO
inhibition	NN
of	IN
tumour	NN
necrosis	NN
factor	NN
(	(
TNF	NN
)	)
-	:
alpha	NN
.	.

The	DT
mechanisms	NNS
that	WDT
underlie	VBP
the	DT
properties	NNS
of	IN
thalidomide	NN
are	VBP
still	RB
unclear	JJ
in	IN
interstitial	JJ
lung	NN
disease	NN
.	.

The	DT
current	JJ
authors	NNS
investigated	VBD
the	DT
potential	JJ
inhibitory	JJ
effects	NNS
of	IN
thalidomide	NN
at	IN
concentrations	NNS
of	IN
0.1	CD
,	,
0.01	CD
and	CC
0.001	CD
mM	NN
on	IN
the	DT
production	NN
of	IN
transforming-growth-factor-beta	NN
,	,
TNF-alpha	NN
,	,
interleukin	NN
(	(
IL	NN
)	)
-1	CD
beta	NN
,	,
IL-6	NN
,	,
IL-8	NN
,	,
IL-10	NN
,	,
IL-12p70	NN
,	,
IL-12p40	NN
and	CC
IL-18	NN
by	IN
alveolar	JJ
macrophages	NNS
from	IN
bronchoalveolar	JJ
lavage	NN
in	IN
patients	NNS
with	IN
sarcoidosis	NN
(	(
n	NN
=	JJ
8	CD
)	)
,	,
hypersensitivity	NN
pneumonitis	NN
(	(
HP	NNP
;	:
n	NN
=	JJ
8	CD
)	)
and	CC
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
;	:
n	NN
=	JJ
12	CD
)	)
.	.

In	IN
sarcoidosis	NN
and	CC
HP	NNP
patients	NNS
,	,
thalidomide	NN
induced	VBD
a	DT
dose-dependent	JJ
,	,
partial	JJ
suppression	NN
of	IN
lipopolysacchride	NN
(	(
LPS	NN
)	)
-	:
stimulated	VBN
TNF-alpha	NN
,	,
IL-12p40	NN
and	CC
IL-18	NN
release	NN
.	.

At	IN
the	DT
highest	JJS
thalidomide	NN
concentration	NN
(	(
0.1	CD
mM	NN
)	)
,	,
LPS-stimulated	JJ
IL-8	NN
production	NN
was	VBD
also	RB
suppressed	VBN
.	.

In	IN
IPF	NN
patients	NNS
,	,
although	IN
spontaneous	JJ
production	NN
of	IN
TNF-alpha	NN
,	,
IL-12p40	NN
,	,
IL-18	NN
and	CC
IL-8	NN
was	VBD
lower	JJR
than	IN
in	IN
sarcoidosis	NN
and	CC
HP	NNP
patients	NNS
,	,
with	IN
LPS	NN
stimulation	NN
the	DT
cytokines	NNS
were	VBD
significantly	RB
elevated	JJ
and	CC
also	RB
partially	RB
inhibited	VBN
by	IN
thalidomide	NN
.	.

In	IN
conclusion	NN
,	,
thalidomide	NN
has	VBZ
the	DT
potential	JJ
to	TO
improve	VB
the	DT
therapeutic	JJ
regimens	NNS
for	IN
sarcoidosis	NN
,	,
hypersensitivity	NN
pneumonitis	NN
and	CC
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
by	IN
reducing	VBG
tumour	NN
necrosis	NN
factor-alpha	NN
,	,
interleukin-12p40	NN
,	,
interleukin-18	NN
and	CC
interleukin-8	NN
production	NN
.	.

